2025 | Sex differences in the risk of incident systemic sclerosis: a nationwide population-based study with subgroup analyses
| SCIENTIFIC REPORTS |
2025 | Comparative risk of incident and recurrent acute anterior uveitis across different biological agents in patients with ankylosing spondylitis | RHEUMATOLOGY |
2025 | Cardiovascular risk according to biological agent exposure in patients with ankylosing spondylitis: a nationwide population-based study | CLINICAL RHEUMATOLOGY |
2025 | Association of Immune-Mediated Inflammatory Diseases and Fracture Risk in Patients with Type 2 Diabetes: A Nationwide Population-Based Study
| JOURNAL OF CLINICAL MEDICINE |
2024 | Incidence rate of recurrent cardiovascular events in patients with radiographic axial spondyloarthritis and the effect of tumor necrosis factor inhibitors
| ARTHRITIS RESEARCH & THERAPY |
2024 | Risk of atrial fibrillation in patients with systemic sclerosis: a nationwide population-based study | RHEUMATOLOGY |
2024 | Drug survival and change of disease activity using a second janus kinase inhibitor in patients with difficult-to-treat rheumatoid arthritis who failed to a janus kinase inhibitor and subsequent biologics
| ADVANCES IN RHEUMATOLOGY |
2024 | Patients with systemic lupus erythematosus who are underweight have distinct disease characteristics | LUPUS |
2023 | Drug Retention Rate and Factors Associated with Discontinuation of Interleukin-17 Inhibitors in Patients with Axial Spondyloarthritis
| YONSEI MEDICAL JOURNAL |
2023 | Higher gamma-glutamyl transferase levels are associated with an increased risk of incident systemic sclerosis: a nationwide population-based study
| SCIENTIFIC REPORTS |
2023 | Systemic sclerosis is a risk factor of incident psoriasis: results from a nationwide cohort study | FRONTIERS IN IMMUNOLOGY |
2023 | Association Between Lipid Profile and Risk of Incident Systemic Sclerosis: A Nationwide Population-Based Study
| CLINICAL EPIDEMIOLOGY |
2023 | Risk of kidney failure in patients with systemic sclerosis: a nationwide population-based study
| RMD OPEN |
2023 | Disease course of non-radiographic axial spondyloarthritis: Data from a long-term retrospective observational cohort
| PLOS ONE |
2023 | Risk of all-cause and cause-specific mortality associated with immune-mediated inflammatory diseases in Korea
| FRONTIERS IN MEDICINE |
2023 | Association of immune-mediated inflammatory diseases with depression and anxiety in patients with type 2 diabetes: A nationwide population-based study
| FRONTIERS IN MEDICINE |
2023 | Interleukin-32 as a biomarker in rheumatic diseases: A narrative review
| FRONTIERS IN IMMUNOLOGY |
2023 | Risk of systemic lupus erythematosus flares according to autoantibody positivity at the time of diagnosis
| SCIENTIFIC REPORTS |
2022 | Correlation between serologic parameters and disease activity of IgG4-related disease: Differences between patients with normal and elevated serum IgG4 concentrations
| FRONTIERS IN IMMUNOLOGY |
2022 | Effects of immune-mediated inflammatory diseases on cardiovascular diseases in patients with type 2 diabetes: a nationwide population-based study
| SCIENTIFIC REPORTS |
2022 | RISK OF SYSTEMIC LUPUS ERYTHEMATOSUS FLARES ACCORDING TO THE POSITIVITY OF AUTOANTIBODIES | ANNALS OF THE RHEUMATIC DISEASES |
2022 | Derivation and Validation of a New Disease Activity Assessment Tool With Higher Accuracy for Takayasu Arteritis
| FRONTIERS IN IMMUNOLOGY |
2022 | Effect of tumor necrosis factor inhibitors on risk of cardiovascular disease in patients with axial spondyloarthritis
| ARTHRITIS RESEARCH & THERAPY |
2022 | BASDAI cut-off values corresponding to ASDAS cut-off values | RHEUMATOLOGY |
2022 | Correlation Between Salivary Microbiome of Parotid Glands and Clinical Features in Primary Sjögren's Syndrome and Non-Sjögren's Sicca Subjects
| FRONTIERS IN IMMUNOLOGY |
2022 | Effect of statins on the prevention of recurrent thrombosis in thrombotic antiphospholipid syndrome | RHEUMATOLOGY |
2022 | Selection of X-ray versus magnetic resonance imaging as a first-line imaging modality for diagnosing axial spondyloarthritis
| THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE |
2021 | Discovery of urine biomarkers for lupus nephritis via quantitative and comparative proteome analysis
| CLINICAL AND TRANSLATIONAL MEDICINE |
2021 | Vascular Uptake on 18 F-FDG PET/CT During the Clinically Inactive State of Takayasu Arteritis Is Associated with a Higher Risk of Relapse
| YONSEI MEDICAL JOURNAL |
2021 | Factors affecting drug survival of an alternative TNF inhibitor and secukinumab in patients with ankylosing spondylitis switching from the first TNF inhibitor
| THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE |
2021 | Tumour necrosis factor inhibitor tapering in patients with ankylosing spondylitis at low disease activity: factors associated with flare
| THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE |
2020 | Non-steroidal anti-inflammatory drugs in patients with stable ankylosing spondylitis receiving tumor necrosis factor inhibitor: continued vs withdrawn | CLINICAL RHEUMATOLOGY |
2020 | Worse Renal Presentation and Prognosis in Initial-Onset Lupus Nephritis than Early-Onset Lupus Nephritis
| YONSEI MEDICAL JOURNAL |
2020 | Effect of Vitamin D Supplementation on Bone Mineral Density in Rheumatoid Arthritis Patients With Osteoporosis
| FRONTIERS IN MEDICINE |
2020 | Disease-specific factors associated with cardiovascular events in patients with Takayasu arteritis
| ARTHRITIS RESEARCH & THERAPY |
2020 | Seroconversion to antinuclear antibody negativity and its association with disease flare in patients with systemic lupus erythematosus | LUPUS |
2020 | Non-histologic factors discriminating proliferative lupus nephritis from membranous lupus nephritis
| ARTHRITIS RESEARCH & THERAPY |
2020 | Plasma immunoglobulin binding protein 1 as a predictor of development of lupus nephritis | LUPUS |
2020 | Negative Regulation of Osteoclast Commitment by Intracellular Protein Phosphatase Magnesium-Dependent 1A | ARTHRITIS & RHEUMATOLOGY |
2020 | Factors Associated With Aggravation of Tubulointerstitial Damage on Repeated Biopsies in Lupus Nephritis Patients With Treatment Failure | CLINICAL AND EXPERIMENTAL RHEUMATOLOGY |
2020 | MiR-451 Suppresses Inflammatory Responses in Ankylosing Spondylitis by Targeting Macrophage Migration Inhibitory Factor | CLINICAL AND EXPERIMENTAL RHEUMATOLOGY |
2020 | Positive conversion of interferon-γ release assay in patients with rheumatic diseases treated with biologics | RHEUMATOLOGY INTERNATIONAL |
2019 | Reply to: Challenging therapeutic goal in large vessel vasculitis | INTERNATIONAL JOURNAL OF CARDIOLOGY |
2019 | Renal flare in class V lupus nephritis: increased risk in patients with tubulointerstitial lesions | RHEUMATOLOGY INTERNATIONAL |